Ticker
NBYCompany Name
NOVABAY PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -7.35M | $ -1.26 | 1 | 5.82M |
3/31/2025 | $ -4.93M | $ -0.93 | 1 | 5.31M |
12/31/2024 | $ -5.18M | $ -1.53 | 1 | 3.4M |
9/30/2024 | $ -4.53M | $ -1.22 | 1 | 3.71M |
6/30/2024 | $ -2.83M | $ -2.45 | 1 | 1.16M |
3/31/2024 | $ -4.09M | $ -5.8 | 1 | 704.91K |
12/31/2023 | $ -4.13M | $ -34.3 | 1 | 120.43K |
9/30/2023 | $ -5.03M | $ -37.49 | 1 | 134.06K |
6/30/2023 | $ -6.35M | $ -70 | 1 | 90.74K |
3/31/2023 | $ -6.21M | $ -106.77 | 1 | 58.14K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for NOVABAY PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -4.71M ] / (Shares WA [ 32.68K ] * Share Factor [ 1 ])
(=) OCFPS [ $ -143.96 ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.66 |
median | $ 0.9 |
std | $ 3.42 |